top of page
GammaTileTherapy-Logo-R_RGB.png

Videos

SURGICALLY TARGETED RADIATION THERAPY FOR PATIENTS WITH OPERABLE BRAIN TUMORS

Note: In January 2020, GammaTile Therapy was FDA cleared for the treatment of newly diagnosed malignant brain tumors of all types in addition to the existing clearance for recurrent brain tumors. 

Physician Interviews

Physician and Patient Perspective | July 20, 2020 | Dr. Clark Chen, neurosurgeon at University of Minnesota Health, and Chad, a patient with recurrent glioblastoma treated with GammaTile Therapy

North Carolina CBS | January 24, 2020 | Vidant Health™ and ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure

Cronkite News, Arizona PBS | October 22, 2019 | Battling brain tumors with time-released radiation

Arizona CBS | August 14, 2019 | New therapy to slow down brain tumors forever changes Arizona woman's life

Minnesota CBS | February 14, 2019 | New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega

Physician Perspective | March 18, 2020 | Dr David McCracken, neurosurgeon at Piedmont Healthcare

Ohio CBS | November 15, 2019 | New brain cancer therapy provides radiation right at tumor site

Videothumb2

Ohio CBS | August 20, 2019 | Mayfield Brain and Spine neurosurgeon using new radiation therapy

Videothumb1.png

Arizona PBS | June 11, 2019 | Implantable brain tumor treatment GammaTile Therapy with Dr David Brachman

Physician Perspective | August 14, 2019 | Dr Clark Chen, neurosurgeon at University of Minnesota Health

Joan's video

GammaTile Science

Introducing GammaTile Therapy

GammaTile Technology

Clinical Presentation | May 1, 2020 | GammaTile Therapy clinical case review with Dr Vincent DiNapoli

The Physics Of A GammaTile Program | September29, 2020 | presented by Dr. Adam Turner, Medical Physicist and consultant for GT Medical Technologies, Inc.

Surgical Footage

Surgical Footage

Glioma Case Example I

Brain Metastases Case Example

GammaTile Therapy is indicated to deliver radiation therapy for patients with newly diagnosed malignant intracranial neoplasms and recurrent intracranial neoplasms.

 

For full safety information, refer to the GammaTile Instructions for Use.

Glioma Case Example II

Meningioma Case Example

bottom of page